Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Regulatory News (ABC)

  • There is currently no data for ABC

Director/PDMR Shareholding

28 Jan 2020 14:29

RNS Number : 1948B
ABCAM PLC
28 January 2020
 

For immediate release

28 January 2020

ABCAM PLC

Director/PDMR Shareholding Notification

Cambridge, UK: Abcam (AIM: ABC, "Abcam" or the "Company"), a global leader in the supply of life science research tools, was notified on 28 January 2020 that on 24 January 2020 Dr Jonathan Milner, a Non-Executive Director of the Company sold, in aggregate, 1,100,000 ordinary shares of 0.2 pence each in the Company ("Ordinary Shares").

These transactions are for tax and estate planning. Dr Milner continues to remain committed to the Company as a member of Abcam's board in his role as Deputy Chairman.

 

As a result of the transactions described above, Dr Milner's total direct and indirect interest in the Company has decreased to a total of 18,009,496 Ordinary Shares, representing approximately 8.74% of the Company's issued share capital.

The Notification of Dealing Form for this transaction is provided below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

For further information, please contact:

Abcam

Marc Perkins, Company Secretary

James Staveley, VP Investor Relations

 

+ 44 (0) 1223 696 000

J.P. Morgan Cazenove - Nominated Advisor

James Mitford

 

+ 44 (0) 20 7742 4000

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr Jonathan S Milner

2

Reason for the notification

a)

Position/status

Deputy Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Abcam plc

b)

Legal Entity Identifier

213800B9N83DSNT33F79

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares

GB00B6774699

b)

Nature of the transaction

Sale by Dr Jonathan S Milner

c)

Currency

GBP - British Pound

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£14.1153

1,100,000

e)

Aggregated information

- Aggregated volume

- Price

 

1,100,000

£14.1153

f)

Date of the transaction

24 January 2020

g)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZVLFLBFLLBBD
Date   Source Headline
1st Oct 20204:41 pmRNSTotal Voting Rights
25th Sep 20201:33 pmRNSDirector/PDMR Shareholding
18th Sep 20202:19 pmRNSBlock listing Interim Review
18th Sep 20207:54 amRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSFull Year Results 2020
11th Sep 202010:34 amRNSNotice of Results
1st Sep 20207:52 amRNSTotal Voting Rights
4th Aug 202012:57 pmRNSTotal Voting Rights
23rd Jul 20207:00 amRNSChange of Adviser
23rd Jul 20207:00 amRNSFull Year Trading Update
2nd Jul 202010:11 amRNSTotal Voting Rights
16th Jun 202012:00 pmRNSDirectorate Change
1st Jun 20209:29 amRNSTotal Voting Rights
11th May 202011:00 amRNSStatement re Update on 2019 AGM Resolution Vote
1st May 202012:24 pmRNSTotal Voting Rights
22nd Apr 202010:11 amRNSHolding(s) in Company
21st Apr 20207:26 amRNSDirector/PDMR Shareholding
20th Apr 202010:19 amRNSHolding(s) in Company
20th Apr 20207:00 amRNSCOVID-19 Update
14th Apr 202010:07 amRNSHolding(s) in Company
9th Apr 20205:33 pmRNSIssue of Shares
2nd Apr 20209:50 amRNSTotal Voting Rights
27th Mar 20203:37 pmRNSHolding(s) in Company
9th Mar 20207:00 amRNSInterim results for 6 months ended 31 Dec 2019
4th Mar 20207:00 amRNSAcquisition of Marker Gene Technologies
2nd Mar 20203:43 pmRNSTotal Voting Rights
2nd Mar 20208:00 amRNSBlock listing Interim Review
4th Feb 202010:49 amRNSTotal Voting Rights
30th Jan 20207:00 amRNSAbcam expands cell engineering capabilities
28th Jan 20202:31 pmRNSHolding(s) in Company
28th Jan 20202:29 pmRNSDirector/PDMR Shareholding
14th Jan 20207:00 amRNSAppointment of Chief Financial Officer
10th Jan 20207:00 amRNSHalf Year Trading Update
2nd Jan 20209:45 amRNSTotal Voting Rights
2nd Jan 20207:00 amRNSTransaction complete between Abcam and Expedeon
19th Dec 201910:05 amRNSHolding(s) in Company
4th Dec 20193:37 pmRNSHolding(s) in Company
2nd Dec 20193:25 pmRNSDirector/PDMR Shareholding
2nd Dec 20199:30 amRNSTotal Voting Rights
21st Nov 201911:42 amRNSHolding(s) in Company
14th Nov 20197:00 amRNSAbcam Capital Markets Event
13th Nov 20194:45 pmRNSResult of AGM
11th Nov 20197:00 amRNSAbcam to acquire proteomics & immunology business
6th Nov 20199:06 amRNSDirector/PDMR Shareholding
1st Nov 201910:55 amRNSTotal Voting Rights
2nd Oct 20194:28 pmRNSHolding(s) in Company
2nd Oct 20191:49 pmRNSDirector/PDMR Shareholding
1st Oct 20192:22 pmRNSTotal Voting Rights
30th Sep 20191:35 pmRNSAnnual Financial Report
26th Sep 20192:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.